Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 81 Results

Title
Intervention Indication Therapeutic Area Year Actions
Inebilizumab for neuromyelitis optica spectrum disorders Inebilizumab (MEDI551) Neuromyelitis optica spectrum disorders Neurology 2024 View  |  Download
Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease including combined pulmonary fibrosis and emphysema Treprostinil (Tyvaso; LIQ861; Orenitram; UT-15C; Remodulin; treprostinil sodium) Pulmonary hypertension Cardiovascular System , Respiratory System 2024 View  |  Download
Irinotecan liposome injection with oxaliplatin, 5-fluorouracil and leucovorin for previously untreated metastatic pancreatic cancer 5-Fluorouracil , Irinotecan liposome injection , Leucovorin , Oxaliplatin Pancreatic cancer Gastrointestinal Cancer 2024 View  |  Download
Linaclotide acetate for treating Chronic idiopathic constipation Linaclotide acetate (MD-1100; Constella) Chronic idiopathic constipation (CIC) Gastroenterology 2024 View  |  Download
Mepolizumab add-on therapy for chronic obstructive pulmonary disease with eosinophil-associated exacerbations Mepolizumab (Nucala; SB-240563; SB-240563 autoinjector) Chronic obstructive pulmonary disease (COPD) Respiratory System 2024 View  |  Download
Mosunetuzumab (subcutaneous injection) for treating relapsed or refractory follicular lymphoma Mosunetuzumab (BTCT4465A) Follicular lymphoma Haematological Cancer and Lymphomas 2024 View  |  Download
Neuro-Cells for treating traumatic spinal cord injury Neuro-Cells Spinal cord injury Musculoskeletal System 2024 View  |  Download
Niraparib with abiraterone acetate and prednisone for treating homologous recombination repair-mutated metastatic castration-sensitive prostate cancer Abiraterone acetate (Zytiga; Yonsa) , Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate) , Prednisone (Decadron; Lodotra) Prostate cancer Male Reproductive Cancer 2024 View  |  Download
Nirogacestat for treating desmoid tumours Nirogacestat (PF-3084014;Ogsiveo) Desmoid Tumour Musculoskeletal System 2024 View  |  Download
Nivolumab for treating advanced clear cell renal cell carcinoma after systemic treatment Nivolumab (Opdivo; BMS-936558; ONO-4538) Renal cell carcinoma (RCC) Renal Cancer 2024 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications